Search Results

There are 7759 results for: content related to: Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: With special reference to age-dependent parameters

  1. Which anticholinergic drug for overactive bladder symptoms in adults

    Intervention Review

    The Cochrane Library

    Priya Madhuvrata, June D Cody, Gaye Ellis, G Peter Herbison and E. Jean C Hay-Smith

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD005429.pub2

  2. Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 6, June 1999, Pages: 672–684, Suneel K. Gupta, Gayatri Sathyan, Elizabeth A. Lindemulder, Pai-Ling Ho, Lewis B. Sheiner and Leon Aarons

    Version of Record online : 17 JUN 1999, DOI: 10.1016/S0009-9236(99)90089-9

  3. You have free access to this content
    Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial

    International Journal of Urology

    Volume 21, Issue 6, June 2014, Pages: 586–593, Osamu Yamaguchi, Eiji Uchida, Naruhito Higo, Hidenao Minami, Shigeo Kobayashi, Hiroyuki Sato and on behalf of the Oxybutynin Patch Study Group

    Version of Record online : 18 DEC 2013, DOI: 10.1111/iju.12372

  4. Pharmacokinetics and Pharmacodynamics of Once-Daily Controlled-Release Oxybutynin and Immediate-Release Oxybutynin

    The Journal of Clinical Pharmacology

    Volume 47, Issue 3, March 2007, Pages: 351–357, Joseph L. Reiz, Paulette Salem and Andrew C. Darke

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006297226

  5. You have free access to this content
    Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor

    BJU International

    Volume 87, Issue 9, June 2001, Pages: 767–773, G. Lose and J.P. Nørgaard

    Version of Record online : 12 JAN 2002, DOI: 10.1046/j.1464-410x.2001.02227.x

  6. Morphological changes in the salivary acini after in vivo cholinergic stimulation

    Neurourology and Urodynamics

    Volume 35, Issue 5, June 2016, Pages: 574–581, Sherif S. Hassan, Raja Rachakatla, Terence McGarvey and Magdy F. Youakeem

    Version of Record online : 25 MAR 2015, DOI: 10.1002/nau.22768

  7. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: A randomized, double-blind, placebo-controlled study

    Neurourology and Urodynamics

    Volume 34, Issue 1, January 2015, Pages: 37–43, Evan R. Goldfischer, Peter K. Sand, Heather Thomas and Jill Peters-Gee

    Version of Record online : 16 OCT 2013, DOI: 10.1002/nau.22504

  8. Investigating Detrusor Muscle Concentrations of Oxybutynin After Intravesical Delivery in an Ex Vivo Porcine Model

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 7, July 2015, Pages: 2233–2240, Nicholas A. Williams, Kay M. Lee, Chris J. Allender, Jenna L. Bowen, Mark Gumbleton, Tim Harrah, Aditya Raja and Hrishi B. Joshi

    Version of Record online : 18 MAY 2015, DOI: 10.1002/jps.24471

  9. You have free access to this content
    Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study

    BJU International

    Volume 106, Issue 4, August 2010, Pages: 550–556, Schahnaz Alloussi, Gerd Mürtz, Reinhard Braun, Ulrich Gerhardt, Martina Heinrich, Eva Hellmis, Werner Horn, Daniela Marschall-Kehrel, Kurt Niklas, Michael Raabe, Thomas Rößler, Beatrix Seibt, Stefan Siemer, Daniela Schultz-Lampel, Heiko Walter, Burkhard Wiedeking, Saladin Alloussi, Paul Bock, Gerhard Strugala and Helmut Madersbacher

    Version of Record online : 11 DEC 2009, DOI: 10.1111/j.1464-410X.2009.09129.x

  10. Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: A randomized, prospective, controlled multi-center trial

    Neurourology and Urodynamics

    Volume 35, Issue 5, June 2016, Pages: 582–588, Annette Schröder, Uwe Albrecht, Jörg Schnitker, André Reitz and Raimund Stein

    Version of Record online : 8 MAR 2015, DOI: 10.1002/nau.22755

  11. You have free access to this content
    A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin

    BJU International

    Volume 85, Issue 7, May 2000, Pages: 793–798, J. Birns, E. Lukkari, J.G. Malone-lee and the Oxybutynin CR Clinical Trial Group

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1464-410x.2000.00623.x

  12. You have free access to this content
    Effect of OROS® controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride

    British Journal of Clinical Pharmacology

    Volume 52, Issue 4, October 2001, Pages: 409–417, Gayatri Sathyan, Michael B. Chancellor and Suneel K. Gupta

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.0306-5251.2001.01463.x

  13. You have free access to this content
    Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder

    British Journal of Urology

    Volume 82, Issue 6, December 1998, Pages: 859–864, Åmark, Eksborg, Juneskans, Bussman and Palm

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1464-410X.1998.00888.x

  14. Urge Urinary Incontinence

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt089

  15. You have free access to this content
    Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice

    British Journal of Pharmacology

    Volume 145, Issue 2, May 2005, Pages: 219–227, Tomomi Oki, Shuichi Sato, Keiji Miyata and Shizuo Yamada

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706184

  16. You have free access to this content
    Comparison of the effects of percutaneous and intraduodenal administration of oxybutynin on bladder contraction and salivation in rabbits

    International Journal of Urology

    Volume 13, Issue 7, July 2006, Pages: 977–984, HITOSHI KONTANI, TETSUKAZU HAMAMOTO, SUNAO TAKEUCHI, YUKARI NOMURA, HIROYUKI SAWANISHI and HARUO SAITO

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1442-2042.2006.01451.x

  17. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature

    International Journal of Clinical Practice

    Volume 65, Issue 5, May 2011, Pages: 567–585, C. C. Sexton, S. M. Notte, C. Maroulis, R. R. Dmochowski, L. Cardozo, D. Subramanian and K. S. Coyne

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1742-1241.2010.02626.x

  18. Risk of Medication-Associated Initiation of Oxybutynin in Elderly Men and Women

    Journal of the American Geriatrics Society

    Volume 62, Issue 4, April 2014, Pages: 690–695, Lisa M. Kalisch Ellett, Nicole L. Pratt, John D. Barratt, Debra Rowett and Elizabeth E. Roughead

    Version of Record online : 17 MAR 2014, DOI: 10.1111/jgs.12741

  19. You have free access to this content
    Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial

    BJU International

    Volume 92, Issue 7, November 2003, Pages: 741–747, Y. Homma, J.S. Paick, J.G. Lee, K. Kawabe and the Japanese and Korean Tolterodine Study Group

    Version of Record online : 27 OCT 2003, DOI: 10.1046/j.1464-410X.2003.04468.x

  20. You have free access to this content
    Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study

    BJU International

    Volume 103, Issue 6, March 2009, Pages: 776–781, Helmut Madersbacher, Gerd Mürtz, Schahnaz Alloussi, Burghard Domurath, Thomas Henne, Iris Körner, Andreas Niedeggen, Joseph Nounla, Jürgen Pannek, Heinrich Schulte-Baukloh, Daniela Schultz-Lampel, Paul Bock and Gerhard Strugala

    Version of Record online : 24 OCT 2008, DOI: 10.1111/j.1464-410X.2008.08093.x